Ashoo Gupta's most recent trade in 4D Molecular Therapeutics Inc was a trade of 865 Restricted Stock Units done . Disclosure was reported to the exchange on March 20, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| 4D Molecular Therapeutics Inc | Ashoo Gupta | VP, Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2026 | 865 | 12,119 | - | - | Restricted Stock Units | |
| 4D Molecular Therapeutics Inc | Ashoo Gupta | VP, Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2026 | 865 | 47,224 | - | - | Common Stock | |
| 4D Molecular Therapeutics Inc | Ashoo Gupta | VP, Finance and Controller | Sale of securities on an exchange or to another person at price $ 8.61 per share. | 20 Mar 2026 | 310 | 46,914 | - | 8.6 | 2,669 | Common Stock |
| 4D Molecular Therapeutics Inc | Ashoo Gupta | VP, Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2026 | 221 | 3,087 | - | - | Restricted Stock Units | |
| 4D Molecular Therapeutics Inc | Ashoo Gupta | VP, Finance and Controller | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Mar 2026 | 221 | 47,135 | - | - | Common Stock | |
| 4D Molecular Therapeutics Inc | Ashoo Gupta | VP, Finance and Controller | Sale of securities on an exchange or to another person at price $ 8.61 per share. | 20 Mar 2026 | 80 | 47,055 | - | 8.6 | 689 | Common Stock |
| 4D Molecular Therapeutics Inc | Ashoo Gupta | VP, Finance and Controller | 20 Dec 2025 | 866 | 46,528 | - | - | Common Stock | ||
| 4D Molecular Therapeutics Inc | Ashoo Gupta | VP, Finance and Controller | 20 Dec 2025 | 866 | 12,984 | - | - | Restricted Stock Units | ||
| 4D Molecular Therapeutics Inc | Ashoo Gupta | VP, Finance and Controller | 20 Dec 2025 | 310 | 46,218 | - | 8.7 | 2,691 | Common Stock | |
| 4D Molecular Therapeutics Inc | Ashoo Gupta | VP, Finance and Controller | 20 Dec 2025 | 220 | 3,308 | - | - | Restricted Stock Units | ||
| 4D Molecular Therapeutics Inc | Ashoo Gupta | VP, Finance and Controller | 20 Dec 2025 | 220 | 46,438 | - | - | Common Stock | ||
| 4D Molecular Therapeutics Inc | Ashoo Gupta | VP, Finance and Controller | 20 Dec 2025 | 79 | 46,359 | - | 8.7 | 686 | Common Stock |